122 related articles for article (PubMed ID: 11378881)
1. Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors.
Port RE; Knopp MV; Brix G
Magn Reson Med; 2001 Jun; 45(6):1030-8. PubMed ID: 11378881
[TBL] [Abstract][Full Text] [Related]
2. Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging.
Port RE; Knopp MV; Hoffmann U; Milker-Zabel S; Brix G
J Magn Reson Imaging; 1999 Sep; 10(3):233-41. PubMed ID: 10508282
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the effect of haematocrit-dependent arterial input functions on the accuracy of pharmacokinetic parameters in dynamic contrast-enhanced MRI.
Just N; Koh DM; D'Arcy J; Collins DJ; Leach MO
NMR Biomed; 2011 Aug; 24(7):902-15. PubMed ID: 21290457
[TBL] [Abstract][Full Text] [Related]
4. Is there a correlation in breast carcinomas between tumor size and number of tumor vessels detected by gadolinium-enhanced magnetic resonance mammography?
Siewert C; Oellinger H; Sherif HK; Blohmer JU; Hadijuana J; Felix R
MAGMA; 1997 Mar; 5(1):29-31. PubMed ID: 9219176
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI.
Alamo L; Fischer U
Eur Radiol; 2001; 11(6):970-7. PubMed ID: 11419173
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
8. [MR-Imaging of lower leg muscle perfusion].
Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
[TBL] [Abstract][Full Text] [Related]
9. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
[TBL] [Abstract][Full Text] [Related]
10. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
[TBL] [Abstract][Full Text] [Related]
11. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y
Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tumor angiogenesis using dynamic enhanced magnetic resonance imaging: comparison of plasma vascular endothelial growth factor, hemodynamic, and pharmacokinetic parameters.
Ikeda O; Nishimura R; Miyayama H; Yasunaga T; Ozaki Y; Tuji A; Yamashita Y
Acta Radiol; 2004 Jul; 45(4):446-52. PubMed ID: 15323399
[TBL] [Abstract][Full Text] [Related]
13. Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameters.
Workie DW; Dardzinski BJ
Magn Reson Med; 2005 Sep; 54(3):560-8. PubMed ID: 16088875
[TBL] [Abstract][Full Text] [Related]
14. Effect of T2* correction on contrast kinetic model analysis using a reference tissue arterial input function at 7 T.
Zhang J; Freed M; Winters K; Kim SG
MAGMA; 2015 Dec; 28(6):555-63. PubMed ID: 26239630
[TBL] [Abstract][Full Text] [Related]
15. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series.
Brix G; Kiessling F; Lucht R; Darai S; Wasser K; Delorme S; Griebel J
Magn Reson Med; 2004 Aug; 52(2):420-9. PubMed ID: 15282828
[TBL] [Abstract][Full Text] [Related]
16. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
Yuen S; Uematsu T; Kasami M; Tanaka K; Kimura K; Sanuki J; Uchida Y; Furukawa H
J Magn Reson Imaging; 2007 Mar; 25(3):502-10. PubMed ID: 17326093
[TBL] [Abstract][Full Text] [Related]
18. Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
Poulin E; Lebel R; Croteau E; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
Magn Reson Med; 2013 Mar; 69(3):781-92. PubMed ID: 22570280
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
